Deutsche Bank’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding LENZ
7IH
Deutsche Bank's LENZ Position: Q3 2026 in Review
Deutsche Bank reduced its LENZ Therapeutics (LENZ) stake by 13% in Q3 2026, selling an estimated $10.3K and leaving 14,219 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3469.
Deutsche Bank first reported a position in LENZ in Q3 2021 and has held it in 13 quarters since. The position peaked at $627K in Q3 2025. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.
- Deutsche Bank held 14,219 shares of LENZ Therapeutics worth $54.6K as of Q3 2026.
- Deutsche Bank sold 2,071 LENZ Therapeutics shares in Q3 2026, an estimated $10.3K.
- LENZ Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3469 holding.
- Deutsche Bank first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 13 quarters since.
- Deutsche Bank's LENZ Therapeutics position peaked at $627K in Q3 2025.
- 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.